Advertisement 
Home arrow News arrow IHA expands instrument capabilities.
IHA expands instrument capabilities.
In October 2008 the Icelandic Heart Association purchased a new instrument for genetic analysis from Illumina to further expand and diversify its genetic research capabilities. IHA has already made significant contribution to the field of genetics in relation to complex diseases.

In October 2008 the Icelandic Heart Association purchased a new instrument for genetic analysis from Illumina to further expand and diversify its genetic research capabilities. IHA has already made significant contribution to the field of genetics in relation to complex diseases. This new technology will undoubtedly improve current knowledge regarding the genetics of heart and vascular disease, diabetes and cancer for publication in peer-reviewed journals.

 

The staff of the genetic department of The Icelandic Heart Association with the new instrument img_2936.jpg